Franklin Resources’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279M Buy
1,488,394
+354,848
+31% +$51.8M 0.06% 260
2026
Q1
$110M Buy
1,133,546
+73,375
+7% +$7.41M 0.03% 410
2025
Q4
$84.4M Buy
1,060,171
+108,681
+11% +$7.13M 0.02% 479
2025
Q3
$44.4M Buy
951,490
+699,710
+278% +$27.4M 0.01% 681
2025
Q2
$9.26M Buy
+251,780
New +$9.67M ﹤0.01% 1157
2020
Q4
Sell
-362,370
Closed -$12.6M 1948
2020
Q3
$12.6M Buy
362,370
+12,300
+4% +$341K 0.01% 859
2020
Q2
$8.82M Buy
350,070
+70
+0% +$2.2K ﹤0.01% 895
2020
Q1
$7.67M Buy
+350,000
New +$9.69M 0.01% 846

Other funds holding RVMD

Franklin Resources's RVMD Position: Q2 2026 in Review

Franklin Resources increased its Revolution Medicines (RVMD) stake by 31% in Q2 2026, buying an estimated $51.8M and bringing the position to 1,488,394 shares worth $279M. The position accounts for 0.06% of the portfolio, ranked #260.

Franklin Resources first reported a position in RVMD in Q1 2020 and has held it in 8 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Franklin Resources held 1,488,394 shares of Revolution Medicines worth $279M as of Q2 2026.
  • Franklin Resources bought 354,848 Revolution Medicines shares in Q2 2026, an estimated $51.8M.
  • Revolution Medicines made up 0.06% of Franklin Resources's portfolio in Q2 2026, its #260 holding.
  • Franklin Resources first reported a position in Revolution Medicines in Q1 2020 and has held it in 8 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.